Tufts: Rise of outsourcing means new R&D models; INC CEO to lead ACRO;

> The rise in Big Pharma outsourcing promises to change the relationship between sponsors and CROs, according to a Tufts report. More

> INC Research ($INCR) CEO Jamie Macdonald is taking the reins as chairman of industry group ACRO. News

Suggested Articles

WIRB-Copernicus Group’s clinical services division bought out trial consultancy firm Waife & Associates as it looks to boost its management services.

After three full business days in the position, an abrupt about-face has LabCorp Diagnostics’ CEO John Ratliff heading for the exit.

The initiative will see Evotec mine a kidney biobank for new renal therapy targets before the joint venture out-licenses resulting assets to Vifor.